Bone Biologics Corp Stock Buy Hold or Sell Recommendation
| BBLGW Stock | USD 20.20 0.00 0.00% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Bone Biologics Corp is 'Not Rated'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Bone Biologics Corp given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Bone Biologics Corp, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. Note, we conduct extensive research on individual companies such as Bone and provide practical buy, sell, or hold advice based on investors' constraints. Bone Biologics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
Bone |
Execute Bone Biologics Buy or Sell Advice
The Bone recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Bone Biologics Corp. Macroaxis does not own or have any residual interests in Bone Biologics Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Bone Biologics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Bone Biologics Trading Alerts and Improvement Suggestions
| Bone Biologics Corp is not yet fully synchronised with the market data | |
| Bone Biologics Corp is way too risky over 90 days horizon | |
| Bone Biologics Corp appears to be risky and price may revert if volatility continues | |
| Bone Biologics Corp has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (4.11 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Bone Biologics Corp has accumulated about 4.44 K in cash with (4.12 M) of positive cash flow from operations. | |
| Bone Biologics Corp has a frail financial position based on the latest SEC disclosures |
Bone Biologics current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Bone analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Bone analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Bone Biologics Returns Distribution Density
The distribution of Bone Biologics' historical returns is an attempt to chart the uncertainty of Bone Biologics' future price movements. The chart of the probability distribution of Bone Biologics daily returns describes the distribution of returns around its average expected value. We use Bone Biologics Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Bone Biologics returns is essential to provide solid investment advice for Bone Biologics.
| Mean Return | 3.73 | Value At Risk | -27.16 | Potential Upside | 31.80 | Standard Deviation | 28.70 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Bone Biologics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Bone Biologics Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | (24.1K) | 6.7M | 862.9K | (4.5M) | 298.6K | 242.8K | |
| Free Cash Flow | (426.9K) | (1.2M) | (3.6M) | (9.6M) | (4.1M) | (3.9M) | |
| Begin Period Cash Flow | 24.1K | 2.5K | 6.7M | 7.5M | 3.0M | 1.7M | |
| Other Cashflows From Financing Activities | 805.6K | 1.1M | 4.4K | 5.0K | 5.0M | 5.3M | |
| Other Non Cash Items | 938.1K | 495.6K | (2.2M) | (892.7K) | (51.1K) | (48.5K) | |
| Total Cash From Operating Activities | (426.9K) | (1.2M) | (3.6M) | (9.6M) | (4.1M) | (3.9M) | |
| Net Income | (1.8M) | (1.6M) | (1.5M) | (8.9M) | (4.1M) | (4.3M) | |
| Total Cash From Financing Activities | 402.8K | 7.9M | 4.4M | 5.0M | 4.4M | 3.0M | |
| End Period Cash Flow | 2.5K | 6.7M | 7.5M | 3.0M | 3.3M | 2.0M | |
| Change In Working Capital | 399.7K | (320.5K) | (168.4K) | 132.9K | (150.3K) | (142.7K) | |
| Stock Based Compensation | 60K | 207.0K | 266.6K | 152.6K | 188.8K | 179.4K |
Note: Acquisition by Musculoskeletal Transplant Foundation, Inc. of 731707 shares of Bone Biologics at 2.05 subject to Rule 16b-3 [view details]
Bone Biologics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Bone . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Bone Biologics Buy or Sell Advice
When is the right time to buy or sell Bone Biologics Corp? Buying financial instruments such as Bone Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Bone Biologics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Long/short ETFs Thematic Idea Now
Long/short ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Long/short ETFs theme has 29 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Long/short ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Bone Stock Analysis
When running Bone Biologics' price analysis, check to measure Bone Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bone Biologics is operating at the current time. Most of Bone Biologics' value examination focuses on studying past and present price action to predict the probability of Bone Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bone Biologics' price. Additionally, you may evaluate how the addition of Bone Biologics to your portfolios can decrease your overall portfolio volatility.